MAPNET’s Drs. Matcheri Keshavan and Raquelle Mesholam-Gately joined Mad in America to discuss their consumer-led project on renaming schizophrenia. You can listen to this podcast or read the transcript here.

“In this interview, [Drs. Keshavan & Mesholam-Gately] discuss what they learned about the issues surrounding the renaming of schizophrenia in their research with consumers and service users. In particular, they reflect on how this psychiatric diagnosis can impact the therapeutic alliance necessary for effective treatment and the overall quality of life of people diagnosed.”